A revolutionary study presented at the European Congress of Obesity (ECO) reveals that semaglutide, which is found in popular weight loss drugs like Wegovy and Ozempic, has the potential to transform cardiovascular health. According to the study, participants who took semaglutide had a 20 percent Read More...